Table 3

An overview of biospecimens collected at baseline from individuals within the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)

Crohn’s disease n=142Ulcerative colitis
n=201
IBD-unclassified n=24Symptomatic control
n=168
Healthy control
n=59
Serum, n (%)137 (96)199 (99)23 (96)164 (98)59 (100)
Faecal, n (%)*99 (70)137 (68)20 (83)112 (67)56 (95)
Intestinal biopsies, n (%)92 (65)161 (80)18 (75)155 (92)58 (98)
Urine, n (%)62 (44)91 (45)9 (38)90 (54)58 (98)
  • *Faecal samples for microbiome analyses and for additional faecal marker. Samples for faecal calprotectin were handled separately.

  • IBD, inflammatory bowel disease.